Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: biosimilar

The ACR, Rheumatologists Advance Issues Through Advocacy

E. William St.Clair, MD  |  May 15, 2015

Rheumatologists and rheumatology health professionals make a difference every day in the lives of patients. And through the work of many devoted members, the College takes that commitment beyond the care setting and into the policy arena to Advance Rheumatology! on Capitol Hill and in state capitols across the country. I want to take a…

Filed under:President's PerspectiveProfessional Topics Tagged with:AdvocacyAmerican College of Rheumatology (ACR)

2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations

Susan Bernstein  |  March 1, 2015

The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingBernsteinDrugsManagementRheumatoid arthritisrheumatologyTreatment

Rheumatology Fellows-in-Training Offer Fresh Perspectives on the ACR/ARHP Annual Meeting

Staff  |  February 1, 2015

Medical residents relay insights on annual meeting sessions, lectures, networking events, and Boston tourism

Filed under:Education & TrainingFrom the CollegeMeeting Reports Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)FellowsrheumatologyTraining

New Opportunities to Advance Rheumatology Through State Advocacy in 2015

Staff  |  January 1, 2015

As state legislatures reconvene, the ACR is identifying states, collaborative partners to help pursue legislation

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyLegislationpolicyRegulationrheumatologystate

The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology

Joseph Flood, MD  |  November 1, 2014

Information technology an overarching theme of this year’s work

Filed under:ConditionsEMRsEULAR/OtherLegislation & AdvocacyMeeting ReportsOsteoarthritis and Bone DisordersPresident's PerspectiveProfessional TopicsSystemic Lupus ErythematosusTechnology Tagged with:AC&RACR/ARHP Annual MeetingAdvocacyAmerican College of Rheumatology (ACR)collaborationelectronic health recordEULARFloodglucocorticoidHenkelLegislationLupusMedicareOsteoporosisrheumatologistrheumatologyTechnology

American Medical Association House of Delegates Annual Meeting Update

Gary L. Bryant, MD  |  October 1, 2014

AMA delegation chair Gary L. Bryant, MD, outlines AMA’s progress with ongoing initiatives, new resolutions submitted by the ACR

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)CongressFundingICD-10LegislationMedicarerheumatologySafety

Update on Legislation, Advocacy Efforts to Advance Rheumatology

Joseph Flood, MD  |  September 1, 2014

Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

Filed under:Billing/CodingBiologics/DMARDsDrug UpdatesLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/ImprovementResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingBiologicsBiosimilarsCodingdrugICD-10LegislationMedicarePractice ManagementResearchrheumatologistSGRTechnology

Rheumatology Advocacy Starts at Home

Joseph Flood, MD  |  August 1, 2014

The ACR expands advocacy efforts to impact state legislatures, local organizations

Filed under:Biologics/DMARDsDrug UpdatesFrom the CollegeLegislation & AdvocacyPresident's PerspectiveProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiosimilarsdrugFloodLegislationlocalrheumatologistrheumatologystate

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisResearch Rheum Tagged with:anti-inflammatoryBiologicsBiosimilarscelecoxib (Elyxyb)corticosteroid psychosisMethotrexatePsoriatic ArthritisradiographraloxifeneResearchrituximabSafety

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences